Our Research

Ohio Pediatrics, in partnership with Ohio Pediatric Research Association, has conducted clinical research studies since 1991. During this time, OPI helped bring to market the Rotateq vaccine (to prevent Rotavirus gastroenteritis), the MMRV combination vaccine, the Pentacel combination vaccine, the Prevnar13 vaccine (an improved vaccination to prevent Pneumococcal disease), the Flumist vaccine for children down to age 2 and most recently the H1N1 vaccine. OPI also participates in numerous formula, allergy, asthma and ADHD studies. For more information about how you can become part of our research family, please call one of our research staff at 937-424-9294.